# Outset Medical, Inc. (OM)

> Source: Nexqual · https://nexqual.com/OM · data as of 2026-10-28 20:00 UTC · cite as "Nexqual, Outset Medical, Inc. (OM), nexqual.com/OM" · informational, not investment advice.

**Price:** USD 4.34 (+0.00% on the day) · last close of Oct 28, 2026; US market closed, not a live price. Prev close 4.34 · day 4.16–4.4 · 52w 2.84–14.25 · market cap null · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $118M, net income -$74.3M (-63.1% margin), free cash flow -$38.9M (SEC filings).
- Total return with dividends: 1Y -67.8%.
- Next earnings: 2026-11-04, EPS estimate USD -0.69, revenue estimate $31.4M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $103M | $115M | $130M | $114M | $119M | $118M |
| Gross profit | $7.6M | $17.8M | $29.0M | $38.6M | $46.8M | — |
| Operating income | -$131M | -$161M | -$170M | -$113M | -$66.7M | -$66.0M |
| Net income | -$132M | -$163M | -$173M | -$128M | -$81.7M | -$74.3M |
| EPS (diluted) | -$43.35 | -$50.70 | -$52.28 | -$36.96 | -$5.37 | — |
| Free cash flow | -$133M | -$154M | -$135M | -$117M | -$47.1M | -$38.9M |
| Gross margin | 7.4% | 15.5% | 22.2% | 33.9% | 39.1% | — |
| Operating margin | -127.2% | -139.6% | -130.2% | -99.7% | -55.8% | -56.1% |
| Net margin | -128.6% | -141.2% | -132.5% | -112.6% | -68.3% | -63.1% |
| Revenue growth | +105.5% | +12.4% | +13.0% | -12.8% | +5.1% | — |
| Cash + short-term investments | $340M | $288M | $203M | $159M | $169M | — |
| Total debt | $29.8M | $101M | $130M | $197M | $96.2M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)


## Total return (dividends reinvested)
|  | 1Y (from 2025-10-29) |
|---|---|
| Total return | -67.8% |
| S&P 500 (SPY) | — |
| Per year | -67.9% |
| Volatility (annualized) | 110.4% |
| Max drawdown | -78.0% (Oct 2025→Sep 2026) |

## More
Full page: https://nexqual.com/OM · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $-0.69 | $-0.62 | −$0.07 | $31.4M | 3 |
| Next quarter (ends 2026-12-31) | $-0.69 | $-0.73 | +$0.03 | $35.0M | 3 |
| Current fiscal year (ends 2026-12-31) | $-3.08 | $-2.89 | −$0.19 | $126.0M | 3 |
| Next fiscal year (ends 2027-12-31) | $-2.29 | $-2.18 | −$0.11 | $139.1M | 3 |

## Earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | −$0.80 | −$0.72 | Miss −11.1% | — |
| — | Quarter ended Mar 31, 2026 | −$0.83 | −$0.79 | Miss −5.1% | — |
| — | Quarter ended Dec 31, 2025 | −$0.84 | −$0.67 | Miss −25.4% | — |
| — | Quarter ended Sep 30, 2025 | −$0.69 | −$0.65 | Miss −6.2% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).

## Recent SEC filings (last 120 days)
| Filed | Form | What it says | Filing |
|---|---|---|---|
| 2026-10-06 | Schedule 13G/A | BML Investment Partners, L.P.: 14.7% of shares, passive 5%+ holder (amended) | https://www.sec.gov/Archives/edgar/data/1484612/000137360426000055/0001373604-26-000055-index.htm |
| 2026-08-28 | 8-K | Director or executive officer change, or pay arrangement — “On August 27, 2026, John Brottem informed Outset Medical, Inc. (the "Company") of his decision to depart from the Company and his role as General Counsel, effective September 11, 2026, to pursue other professional opportunities. Mr. Brottem's departure is not due to any dispute or disagreement with the Company or its management.” | https://www.sec.gov/Archives/edgar/data/1484612/000119312526374323/0001193125-26-374323-index.htm |
| 2026-08-12 | Schedule 13G/A | BANK OF AMERICA CORP /DE/: 3.5% of shares, passive 5%+ holder (amended) | https://www.sec.gov/Archives/edgar/data/1484612/000007085826000433/0000070858-26-000433-index.htm |
| 2026-08-12 | Schedule 13G | AQR Capital Management, LLC, AQR Capital Management Holdings, LLC: 5.4% of shares, passive 5%+ holder | https://www.sec.gov/Archives/edgar/data/1484612/000116755726000142/0001167557-26-000142-index.htm |
| 2026-08-06 | 10-Q | Quarterly report · period ended Jun 30, 2026 | https://www.sec.gov/Archives/edgar/data/1484612/000119312526338432/0001193125-26-338432-index.htm |
| 2026-08-06 | 8-K | Quarterly results | https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/0001193125-26-337953-index.htm |
| 2026-07-29 | Schedule 13G/A | BlackRock, Inc.: 2.0% of shares, passive 5%+ holder (amended) | https://www.sec.gov/Archives/edgar/data/1484612/000201238326002921/0002012383-26-002921-index.htm |
Source: SEC EDGAR. Quotes are the opening words of each item as filed.